Latest News about BVNRY
Recent news which mentions BVNRY
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
September 17, 2024
From Benzinga
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
From Benzinga
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic
September 06, 2024
From Benzinga
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
August 26, 2024
From Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
From Benzinga
From Benzinga
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
August 16, 2024
From Benzinga
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
August 15, 2024
From Benzinga
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
August 14, 2024
From Benzinga
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data
June 20, 2023
From Benzinga
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines
February 15, 2023
From Benzinga
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
December 15, 2022
From Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
November 03, 2022
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
From Benzinga
From Benzinga
3 Top Monkeypox Stocks to Buy Right Now
August 24, 2022
From InvestorPlace
PTON Stock Pops as Peloton Products Launch on Amazon
August 24, 2022
From InvestorPlace
From InvestorPlace
From Benzinga
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies
August 24, 2022
From Benzinga
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
August 23, 2022
From Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
August 19, 2022
From Benzinga
From Benzinga
From Benzinga
World’s only monkeypox vaccine maker uncertain it can meet demand, Bavarian Nordic CEO warns
August 17, 2022
Tickers
BVNRY
From MarketWatch
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
August 17, 2022
From InvestorPlace
From Benzinga
From InvestorPlace